<DOC>
	<DOCNO>NCT02492880</DOCNO>
	<brief_summary>This prospective , on-label , multi-center , non-randomized , exploratory , single-arm study characterize effect program feature Boston Scientific Precision Spectra™ Spinal Cord Stimulator ( SCS ) System use CoverEdge™ surgical lead .</brief_summary>
	<brief_title>CoverEdge Algorithm Programming Study</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Subject implant , onlabel , commercially approve Boston Scientific Spectra neurostimulation system least one CoverEdge CoverEdge X surgical lead , per local direction use ( DFU ) . Subject sign valid , Institutional Review Board ( IRB ) approve informed consent form . Subject 18 year age old write informed consent obtain . Subject meet contraindication Boston Scientific ( BSC ) neurostimulation system local DFU . Subject currently diagnose cognitive impairment , exhibit characteristic , would limit study candidate 's ability ass pain relief complete study assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>stimulation</keyword>
	<keyword>implantable</keyword>
	<keyword>pulse generator</keyword>
	<keyword>back pain</keyword>
	<keyword>chronic pain</keyword>
	<keyword>leg pain</keyword>
</DOC>